Dose proportionality [Regulatives / Guidelines]

posted by Ravi  – India, 2009-05-15 09:43 (5880 d 05:22 ago) – Posting: # 3683
Views: 4,475

Dear All,

Is there any regularity guidline about How to access the dose proportionality in a parallel and crossover biostudy?

We have just conducted a Parallel, 1 period, three treatment, single dose, investigational pilot study on 18 healthy volunteers. Treatments which were used in this study were (1). Test1 (one 100mg tablet of drug X), (2). Test2 (Two 100mg tablets of drug X), (3). Test3 (No tablet or drug X was given). Group receving Test3 is considered as a control group.
Is it possible to access dose proportionality in this type of study. If yes please give me some detail about how to access dose proportionality in this study.

Waiting for your valuable suggestion.

Thanks & Regards
Ravi Pandey

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,677 registered users;
52 visitors (0 registered, 52 guests [including 15 identified bots]).
Forum time: 15:05 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5